FIELD: chemical-pharmaceutical industry.
SUBSTANCE: it has been suggested to apply a solid composition for manufacturing a pharmaceutical tablet or a suppository, its melting point being 25°C or higher and it contains an uninterrupted lipid component that contains either one or more than one galactolipids, one or more glyceride ether of fatty acids, possibly one or several out of the following: water and mono-triatomic alcohol at the quantity being up to 15 weight% against the weight of composition, and one or more agent chosen among pharmacologically active agent. The method for manufacturing the composition mentioned includes mixing galactolipids and glyceride ethers of fatty acids followed by dissolving pharmacologically active agents in a liquid phase, cooling up to a solid state and forming a tablet or a filled capsule. Pharmaceutical tablet or suppository are depicted that include uninterrupted lipid phase possibly containing an inert nucleus and, also, food tablets or suppositories of similar composition that include food agents instead of pharmacologically active agent and, possibly, having got one or more submembranes consisting of food excipients. The innovation provides economy and increased comfort in usage.
EFFECT: higher efficiency.
42 cl, 13 ex, 10 tbl
Title | Year | Author | Number |
---|---|---|---|
LIPOPHILIC CARRIER PREPARATIONS | 1995 |
|
RU2127124C1 |
COMPOSITION FORMING LIPID LAYER AND APPLICABLE ON LIVING BODY'S SURFACE | 2010 |
|
RU2578430C2 |
BILAYER PREPARATIONS | 1995 |
|
RU2166332C2 |
EMULSION OF TYPE "OIL-IN-WATER", CARRIER ON ITS BASE AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2131266C1 |
METHOD OF INDUCING SATIETY | 2015 |
|
RU2690672C2 |
MICROEMULSION USED AS CARRIER FOR ADMINISTRATION OF ACTIVE COMPOUNDS AND METHOD OF ITS PREPARING | 1996 |
|
RU2164134C2 |
CREAMER | 2019 |
|
RU2791985C2 |
THERAPEUTIC APPLICATION OF KRILL OIL | 2012 |
|
RU2625760C2 |
COMPOSITION CONTAINING PARTICLES | 2015 |
|
RU2696482C2 |
LIPID PRECONCENTRATE WITH SUSTAINED RELEASE OF PHARMACOLOGICALLY ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION CONTAINING IT | 2012 |
|
RU2632433C2 |
Authors
Dates
2007-07-10—Published
2003-02-14—Filed